The potential benefits from respiratory gating for breast cancer patients regarding target coverage and dose to organs at risk when applying strict dose limits to the heart: results from the DBCG HYPO trial.
about
The potential benefits from respiratory gating for breast cancer patients regarding target coverage and dose to organs at risk when applying strict dose limits to the heart: results from the DBCG HYPO trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The potential benefits from re ...... ults from the DBCG HYPO trial.
@en
The potential benefits from re ...... ults from the DBCG HYPO trial.
@nl
type
label
The potential benefits from re ...... ults from the DBCG HYPO trial.
@en
The potential benefits from re ...... ults from the DBCG HYPO trial.
@nl
prefLabel
The potential benefits from re ...... ults from the DBCG HYPO trial.
@en
The potential benefits from re ...... ults from the DBCG HYPO trial.
@nl
P2093
P2860
P1433
P1476
The potential benefits from re ...... ults from the DBCG HYPO trial.
@en
P2093
Birgitte V Offersen
Christina Maria Lutz
Ebbe L Lorenzen
Henrik D Nissen
Ingelise Jensen
Lasse Refsgaard
Martin Berg
Mette S Thomsen
P2860
P304
P356
10.1080/0284186X.2017.1406139
P577
2017-12-05T00:00:00Z